RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice

dc.contributor.authorRichter, Antje M.
dc.contributor.authorWoods, Michelle L.
dc.contributor.authorKüster, Miriam M.
dc.contributor.authorWalesch, Sara K.
dc.contributor.authorBraun, Thomas
dc.contributor.authorBoettger, Thomas
dc.contributor.authorDammann, Reinhard H.
dc.date.accessioned2022-08-22T13:57:17Z
dc.date.available2022-08-22T13:57:17Z
dc.date.issued2020
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/6665
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-6116
dc.language.isoen
dc.rightsNamensnennung 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddcddc:570
dc.titleRASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
dc.typearticle
local.affiliationFB 08 - Biologie und Chemie
local.source.epage3127
local.source.journaltitleOncogene
local.source.spage3114
local.source.urihttps://doi.org/10.1038/s41388-020-1195-6
local.source.volume39

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
10.1038_s41388-020-1195-6.pdf
Größe:
3.48 MB
Format:
Adobe Portable Document Format